Baker Bros. Advisors’s Ventyx Biosciences VTYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,349,280
Closed -$21.2M 93
2025
Q4
$21.2M Buy
2,349,280
+1,326,150
+130% +$9.91M 0.12% 49
2025
Q3
$3.18M Buy
+1,023,130
New +$2.71M 0.02% 76

Other funds holding VTYX

Baker Bros. Advisors's VTYX Position: Q1 2026 in Review

Baker Bros. Advisors sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 2,349,280 shares — an estimated $21.2M sold.

Baker Bros. Advisors first reported a position in VTYX in Q3 2025 and held it in 2 quarters. The position peaked at $21.2M in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

  • Baker Bros. Advisors reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
  • Baker Bros. Advisors sold 2,349,280 Ventyx Biosciences shares in Q1 2026, an estimated $21.2M.
  • Baker Bros. Advisors first reported a position in Ventyx Biosciences in Q3 2025 and held it in 2 quarters.
  • Baker Bros. Advisors's Ventyx Biosciences position peaked at $21.2M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Baker Bros. Advisors's 13F filing for Q1 2026, filed 15 May 2026.